journal
https://read.qxmd.com/read/38625443/a-hierarchical-bayesian-approach-to-small-area-estimation-of-health-insurance-coverage-in-ethiopian-administrative-zones-for-better-policies-and-programs
#1
JOURNAL ARTICLE
Yegnanew A Shiferaw, Seyifemickael Amare Yilema, Yikeber Abebaw Moyehodie
Sample surveys are extensively used to provide reliable direct estimates for large areas or domains with enough sample sizes at national and regional levels. However, zones are unplanned domains by the Demographic and Health Survey (DHS) program and need more sample sizes to produce direct survey estimates with adequate precision. Conducting surveys in small areas (like zones) is too expensive and time-consuming, making it unfeasible for developing countries like Ethiopia. Therefore, this study aims to use the Hierarchical Bayes (HB) Small Area Estimation (SAE) model to estimate the Community-Based Health Insurance (CBHI) coverage at the zone levels in Ethiopia...
April 16, 2024: Health Economics Review
https://read.qxmd.com/read/38613583/heterogeneous-effects-of-hospital-competition-on-inpatient-quality-an-analysis-of-five-common-diseases-in-china
#2
JOURNAL ARTICLE
Yinghui Lu, Qingling Jiang, Xueli Zhang, Xiaojun Lin, Jay Pan
BACKGROUND: Many countries has introduced pro-competition policies in the delivery of healthcare to improve medical quality, including China. With the increasing intensity of competition in China's healthcare market, there are rising concerns among policymakers about the impact of hospital competition on quality. This study investigated heterogeneous effects of hospital competition on inpatient quality. METHODS: We analyzed the inpatient discharge dataset and selected chronic obstructive pulmonary disease (COPD), ischemic stroke, pneumonia, hemorrhagic stroke, and acute myocardial infarction (AMI) as representative diseases...
April 13, 2024: Health Economics Review
https://read.qxmd.com/read/38607501/examining-confidential-wholesale-margin-estimates-in-european-countries-for-the-price-negotiation-of-patented-drugs-in-germany-a-statistical-model
#3
JOURNAL ARTICLE
Iris An der Heiden, Guido Schiffhorst, Laura Müller, Martin Albrecht, Arne Bartol, Stefanie Wiberny
BACKGROUND: Based on the legal framework laid down in section 130b (9) of Book V of the German Social Code, various criteria are relevant for the negotiated price for new patented drugs in Germany. European reference prices (ERPs) are one criterion. The ERP is based on the ex-factory prices (EFPs) of the countries included in the European country basket. However, in some of these countries, the EFP is not published due to confidential wholesale margins. Wholesale margins must therefore be estimated and deducted from purchase prices...
April 12, 2024: Health Economics Review
https://read.qxmd.com/read/38564113/the-long-term-cost-effectiveness-of-once-weekly-semaglutide-versus-sitagliptin-for-the-treatment-of-type-2-diabetes-in-china
#4
JOURNAL ARTICLE
Shuyan Gu, Jinghong Gu, Xiaoyong Wang, Xiaoling Wang, Lu Li, Hai Gu, Biao Xu
BACKGROUND: To estimate the long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin as an add-on therapy for type 2 diabetes patients inadequately controlled on metformin in China, to better inform healthcare decision making. METHODS: The Cardiff diabetes model which is a Monte Carlo micro-simulation model was used to project short-term effects of once-weekly semaglutide versus sitagliptin into long-term outcomes. Short-term data of patient profiles and treatment effects were derived from the 30-week SUSTAIN China trial, in which 868 type 2 diabetes patients with a mean age of 53...
April 2, 2024: Health Economics Review
https://read.qxmd.com/read/38557700/uhc-in-morocco-a-bottom-up-estimation-of-public%C3%A2-hospitals-financing-size-based-on-a-costing-database
#5
JOURNAL ARTICLE
El Houcine Akhnif, Abdelouahab Belmadani, Awad Mataria, Maryam Bigdeli
BACKGROUND: Morocco is engaged in a health system reform aimed at generalizing health insurance across the whole population by 2025. This study aims to build a national database of costs at all levels of public hospitals in Morocco and craft this database as a resource for further use in a strategic purchasing system. It also aims at estimating the funding gap and the budget that should be secured for public hospitals in Morocco to fully play their roles in the current ambitious reform...
April 1, 2024: Health Economics Review
https://read.qxmd.com/read/38514523/preferences-in-adolescents-and-young-people-s-sexual-and-reproductive-health-services-in-nigeria-a-discrete-choice-experiment
#6
JOURNAL ARTICLE
Olujide Arije, Jason Madan, Tintswalo Hlungwani
BACKGROUND: Barriers to utilization of sexual and reproductive health (SRH) services by adolescents and young people (AYP) have persisted despite evidence that youth-friendly services have a positive effect on contraceptive use, and patient knowledge and satisfaction. OBJECTIVE: The objective of this study was to elicit, and derive relative valuations for, attributes of SRH services that adolescents and young people value, and their willingness to pay for these services, in public health facilities...
March 22, 2024: Health Economics Review
https://read.qxmd.com/read/38512590/insurance-barriers-and-inequalities-in-health-care-access-evidence-from-dual-practice
#7
JOURNAL ARTICLE
Eva Goetjes, Katharina E Blankart
BACKGROUND: We investigate access disparities in pharmaceutical care among German patients with type 2 diabetes, focusing on differences between public and private health insurance schemes. The primary objectives include investigating whether patients with private health insurance experience enhanced access to antidiabetic care and analyzing whether the treatment received by public and private patients is influenced by the practice composition, particularly the proportion of private patients...
March 21, 2024: Health Economics Review
https://read.qxmd.com/read/38492098/impact-of-reimbursement-systems-on-patient-care-a-systematic-review-of-systematic-reviews
#8
REVIEW
Eva Wagenschieber, Dominik Blunck
BACKGROUND: There is not yet sufficient scientific evidence to answer the question of the extent to which different reimbursement systems influence patient care and treatment quality. Due to the asymmetry of information between physicians, health insurers and patients, market-based mechanisms are necessary to ensure the best possible patient care. The aim of this study is to investigate how reimbursement systems influence multiple areas of patient care in form of structure, process and outcome indicators...
March 16, 2024: Health Economics Review
https://read.qxmd.com/read/38491307/the-economic-effect-of-financial-compensation-in-china-s-healthcare-system-comprehensive-insights-regarding-supply-and-demand-factors
#9
JOURNAL ARTICLE
Yi Guo, Xuezhi Hong, Dongmei Li, Qiannan An, Wenwen Fan, Minghe Yang, Luyang Xiao
OBJECTIVES: We aim to analyse the effects of government subsidies on residents' health and healthcare expenditure from the perspectives of supply and demand. DATA AND METHODS: According to the regional division adopted in the data query system of the National Bureau of Statistics, this study divides 31 provinces and cities into three regions: eastern, central, and western. The data used are from public databases, such as the "China Statistical Yearbook," "China Health Statistical Yearbook," and "Government Final Account Report"...
March 16, 2024: Health Economics Review
https://read.qxmd.com/read/38466522/correction-universal-health-coverage-in-the-context-of-population-ageing-catastrophic-health-expenditure-and-unmet-need-for-healthcare
#10
Shohei Okamoto, Mizuki Sata, Megumi Rosenberg, Natsuko Nakagoshi, Kazuki Kamimura, Kohei Komamura, Erika Kobayashi, Junko Sano, Yuzuki Hirazawa, Tomonori Okamura, Hiroyasu Iso
No abstract text is available yet for this article.
March 11, 2024: Health Economics Review
https://read.qxmd.com/read/38460047/correction-inequalities-in-unmet-health-care-needs-under-universal-health-insurance-coverage-in-china
#11
Jingxian Wu, Yongmei Yang, Ting Sun, Sucen He
No abstract text is available yet for this article.
March 9, 2024: Health Economics Review
https://read.qxmd.com/read/38446368/catastrophic-health-expenditures-a-disproportionate-risk-in-uninsured-ethnic-minorities-with-diabetes
#12
JOURNAL ARTICLE
Sebastian Linde, Leonard E Egede
BACKGROUND: Chargemaster prices are the list prices that providers and health systems assign to each of their medical services in the US. These charges are often several factors of magnitude higher than those extended to individuals with either private or public insurance, however, these list prices are billed in full to uninsured patients, putting them at increased risk of catastrophic health expenditures (CHE). The objective of this study was to examine the risk of CHE across insurance status, diabetes diagnosis and to examine disparity gaps across race/ethnicity...
March 6, 2024: Health Economics Review
https://read.qxmd.com/read/38427081/end-of-life-expenditure-on-health-care-for-the-older-population-a-scoping-review
#13
REVIEW
Ewa Kocot, Azzurra Ferrero, Shibu Shrestha, Katarzyna Dubas-Jakóbczyk
BACKGROUND: The existing evidence shows that the pattern of health expenditure differs considerably between people at the end-of-life and people in other periods of their lives. The awareness of these differences, combined with a detailed analysis of future mortality rates is one of the key pieces of information needed for health spending prognoses. The general objective of this review was to identify and map the existing empirical evidence on end-of-life expenditure related to health care for the older population...
March 1, 2024: Health Economics Review
https://read.qxmd.com/read/38411764/timing-of-preventive-behavior-in-the-case-of-a-new-and-evolving-health-risk-the-case-of-covid-19-vaccination
#14
JOURNAL ARTICLE
Deeksha Gupta, Caroline Rudisill
BACKGROUND: Time preferences for preventive behavior under novel risks and uncertain contexts may differ from timing preferences related to familiar risks. Therefore, it is crucial to examine drivers of preventative health behavior timing in light of new health risks. Using the case of COVID-19, we examine factors affecting vaccination timing plans when vaccines were widely available in the European Union (EU). METHODS: We use data from the Flash Eurobarometer 494 survey (May 21-26, 2021), which collected information on EU residents' attitudes towards COVID-19 vaccinations...
February 27, 2024: Health Economics Review
https://read.qxmd.com/read/38386093/correction-a-comparative-study-of-bibliometric-analysis-on-old-adults-cognitive-impairment-based-on-web-of-science-and-cnki-via-citespace
#15
Shuyi Yan, Mingli Pang, Jieru Wang, Rui Chen, Hui Liu, Xixing Xu, Bingsong Li, Qinling Li, Fanlei Kong
No abstract text is available yet for this article.
February 22, 2024: Health Economics Review
https://read.qxmd.com/read/38372932/public-health-spending-in-sub-saharan-africa-exploring-transmission-mechanisms-using-the-latent-growth-curve-mediation-model
#16
JOURNAL ARTICLE
Wa Ntita Serge Kabongo, Josue Mbonigaba
In response to the imperatives of universal health coverage, structural factors that may hinder the effectiveness of increased spending in sub-Saharan Africa (SSA) need attention. This study assessed the mediating role of these factors in domestic general government health expenditure (DGGHE) effects to propose solutions for improving population health outcomes (PHO). The analysis used the Latent Growth Curve Mediation Model (LGCMM) approach within the structural equation model (SEM) framework for panel data from 42 SSA countries from 2015 to 2018...
February 19, 2024: Health Economics Review
https://read.qxmd.com/read/38367132/the-economic-costs-of-orthopaedic-services-a-health-system-cost-analysis-of-tertiary-hospitals-in-a-low-income-country
#17
JOURNAL ARTICLE
Pakwanja Twea, David Watkins, Ole Frithjof Norheim, Boston Munthali, Sven Young, Levison Chiwaula, Gerald Manthalu, Dominic Nkhoma, Peter Hangoma
BACKGROUND: Traumatic injuries are rising globally, disproportionately affecting low- and middle-income countries, constituting 88% of the burden of surgically treatable conditions. While contributing to the highest burden, LMICs also have the least availability of resources to address this growing burden effectively. Studies on the cost-of-service provision in these settings have concentrated on the most common traumatic injuries, leaving an evidence gap on other traumatic injuries. This study aimed to address the gap in understanding the cost of orthopaedic services in low-income settings by conducting a comprehensive costing analysis in two tertiary-level hospitals in Malawi...
February 17, 2024: Health Economics Review
https://read.qxmd.com/read/38363408/cost-utility-and-cost-effectiveness-analysis-of-disease-modifying-drugs-of-relapsing-remitting-multiple-sclerosis-a-systematic-review
#18
REVIEW
Nasrin Abulhasanbeigi Gallehzan, Majid Khosravi, Khosro Jamebozorgi, Nazanin Mir, Habib Jalilian, Samira Soleimanpour, Saeed Hoseini, Aziz Rezapour, Abbas Eshraghi
BACKGROUND: Multiple sclerosis (MS) is a chronic, autoimmune, and inflammatory disease. The economic burden of MS is substantial, and the high cost of Disease-modifying drugs (DMDs) prices are the main drivers of healthcare expenditures. We conducted a systematic review of studies evaluating the cost-utility and cost-effectiveness of DMDs for relapsing-remitting multiple sclerosis (RRMS). MATERIALS AND METHOD: Searches were conducted in PubMed, Web of Science, Scopus, and Embase...
February 16, 2024: Health Economics Review
https://read.qxmd.com/read/38329561/evaluating-the-costs-of-adverse-drug-events-in-hospitalized-patients-a-systematic-review
#19
REVIEW
Maxime Durand, Christel Castelli, Clarisse Roux-Marson, Jean-Marie Kinowski, Géraldine Leguelinel-Blache
BACKGROUND: Adverse drug events (ADEs) are not only a safety and quality of care issue for patients, but also an economic issue with significant costs. Because they often occur during hospital stays, it is necessary to accurately quantify the costs of ADEs. This review aimed to investigate the methods to calculate these costs, and to characterize their nature. METHODS: A systematic literature review was conducted to identify methods used to assess the cost of ADEs on Medline, Web of Science and Google Scholar...
February 8, 2024: Health Economics Review
https://read.qxmd.com/read/38319466/estimation-of-lifetime-productivity-loss-from-patients-with-chronic-diseases-methods-and-empirical-evidence-of-end-stage-kidney-disease-from-taiwan
#20
JOURNAL ARTICLE
Fuhmei Wang, Jing-Shiang Hwang, Wen-Yen Huang, Yu-Tzu Chang, Jung-Der Wang
OBJECTIVE: Studies that examine the broad allocation of resources, regardless of who bears the costs, should ideally estimate costs from a societal perspective. We have successfully integrated survival rates, employment ratios, and earnings to address the significant challenge of evaluating societal value through productivity assessments of patients with end-stage kidney disease (ESKD) in Taiwan. METHODS: Using a theoretical framework, we interconnected two nationwide databases: the Taiwan National Health Insurance (NHI) and the Taiwan Mortality Registry from 2000 to 2017...
February 6, 2024: Health Economics Review
journal
journal
44047
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.